Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers?

References

• Abbasian M, Massoumi B, Mohammad-Rezaei R, Samadian H, Jaymand M. 2019. Scaffolding polymeric biomaterials: are naturally occurring biological macromolecules more appropriate for tissue engineering? Int J Biol Macromol. 134:673–694.
   PubMed Web of Science ®Google Scholar
• Abdelhalim MAK, Jarrar BM. 2012. Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration. J Nanobiotechnol. 10:5.
   PubMed Web of Science ®Google Scholar
• Abdella EM. 2012. Short-term comparative study of the cyclophosphamide genotoxicity administered free and liposome-encapsulated in mice. Iran J Cancer Prev. 5:51–60.
   PubMedGoogle Scholar
• Abdellatif AA, Tawfeek HM. 2016. Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin. AAPS PharmSciTech. 17:1067–1074.
   PubMed Web of Science ®Google Scholar
• Abdulbaqi IM, Darwis Y, Khan NAK, Assi RA, Khan AA. 2016. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine. 11:2279–2304.
   PubMed Web of Science ®Google Scholar
• Abidin L, Mujeeb M, Imam SS, Aqil M, Khurana D. 2016. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment. Drug Deliv. 23:1069–1074.
   Web of Science ®Google Scholar
• Agarwal M, Murugan M, Sharma A, Rai R, Kamboj A, Sharma H, K Roy S. 2013. Nanoparticles and its toxic effects: a review. Int J Curr Microbial Sci. 2:34–39.
   Google Scholar
• Akiladevi D, Basak S. 2010. Ethosomes—a noninvasive approach for transdermal drug delivery. Int J Curr Pharm Res. 2:1–4.
   Google Scholar
• Alabi CA, Love KT, Sahay G, Stutzman T, Young WT, Langer R, Anderson DG. 2012. FRET-labeled siRNA probes for tracking assembly and disassembly of siRNA nanocomplexes. ACS Nano. 6:6133–6141.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. 2012. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 14:1–16.
   PubMed Web of Science ®Google Scholar
• Albertini RJ. 2001. HPRT mutations in humans: biomarkers for mechanistic studies. Mutat Res. 489:1–16.
   PubMed Web of Science ®Google Scholar
• Albuquerque J, Moura C, Sarmento B, Reis S. 2015. Solid lipid nanoparticles: a potential multifunctional approach towards rheumatoid arthritis theranostics. Molecules. 20:11103–11118.
   PubMed Web of Science ®Google Scholar
• Alegría-Torres JA, Baccarelli A, Bollati V. 2011. Epigenetics and lifestyle. Epigenomics. 3:267–277.
   PubMed Web of Science ®Google Scholar
• Ames BN, Durston WE, Yamasaki E, Lee FD. 1973. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA. 70:2281–2285.
   PubMed Web of Science ®Google Scholar
• Aye M, Di Giorgio C, Berque-Bestel I, Aime A, Pichon BP, Jammes Y, Barthelemy P, De Meo M. 2013. Genotoxic and mutagenic effects of lipid-coated CdSe/ZnS quantum dots. Mutat Res. 750:129–138.
   PubMed Web of Science ®Google Scholar
• Baek JS, Cho CW. 2017. A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget. 8:30369.
   PubMedGoogle Scholar
• Bahadori F, Kocyigit A, Onyuksel H, Dag A, Topcu G. 2017. Cytotoxic, apoptotic and genotoxic effects of lipid-based and polymeric nano micelles, an in vitro evaluation. Toxics. 6:7.
   Web of Science ®Google Scholar
• Bakand S, Hayes A, Dechsakulthorn F. 2012. Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal Toxicol. 24:125–135.
   PubMed Web of Science ®Google Scholar
• Baldwin EL, Byl JAW, Osheroff N. 2004. Cobalt enhances DNA cleavage mediated by human topoisomerase IIα in vitro and in cultured cells. Biochemistry. 43:728–735.
   PubMed Web of Science ®Google Scholar
• Barabadi H, Najafi M, Samadian H, Azarnezhad A, Vahidi H, Mahjoub MA, Koohiyan M, Ahmadi A. 2019. A systematic review of the genotoxicity and antigenotoxicity of biologically synthesized metallic nanomaterials: are green nanoparticles safe enough for clinical marketing? Medicina. 55:439.
   Web of Science ®Google Scholar
• Barenholz YC. 2012. Doxil®—the first FDA-approved nano-drug: lessons learned. J Control Release. 160:117–134.
   PubMed Web of Science ®Google Scholar
• Bartsch M, Weeke-Klimp AH, Hoenselaar EP, Stuart MC, Meijer DK, Scherphof GL, Kamps JA. 2004. Stabilized lipid coated lipoplexes for the delivery of antisense oligonucleotides to liver endothelial cells in vitro and in vivo. J Drug Target. 12:613–621.
   PubMed Web of Science ®Google Scholar
• Barzilai A, Yamamoto KI. 2004. DNA damage responses to oxidative stress. DNA Repair. 3:1109–1115.
   PubMed Web of Science ®Google Scholar
• Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Nair MK, Hoelzer K, et al. 2001. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol. 19:1444–1454.
   PubMed Web of Science ®Google Scholar
• Benford DJ, Hanley AB, Bottrill K, Oehlschlager S, Balls M, Branca F, Castegnaro JJ, Descotes J, Hemminiki K, Lindsay D, et al. 2000. Biomarkers as predictive tools in toxicity testing: the report and recommendations of ECVAM workshop 40. Alternat Lab Anim. 28:119–131.
   Web of Science ®Google Scholar
• Beroström K, Österberg E, Holmberg K, Hoffman AS, Schuman TP, Kozlowski A, Harris JM. 1995. Effects of branching and molecular weight of surface-bound poly (ethylene oxide) on protein rejection. J Biomater Sci Polym Ed. 6:123–132.
   Web of Science ®Google Scholar
• Bhalekar MR, Madgulkar AR, Desale PS, Marium G. 2017. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis. Drug Dev Ind Pharm. 43:1003–1010.
   PubMed Web of Science ®Google Scholar
• Bhattacharya K, Davoren M, Boertz J, Schins RP, Hoffmann E, Dopp E. 2009. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol. 6:17.
   PubMed Web of Science ®Google Scholar
• Bladé J, Sonneveld P, Miguel JFS, Sutherland HJ, Hajek R, Nagler A, Spencer A, Robak T, Lantz KC, Zhuang SH, et al. 2011. Efficacy and safety of pegylated liposomal doxorubicin in combination with bortezomib for multiple myeloma: effects of adverse prognostic factors on outcome. Clin Lymphoma Myeloma Leuk. 11:44–49.
   PubMed Web of Science ®Google Scholar
• Bolt HM. 2014. Grouping of nanomaterials for risk assessmented. Berlin: Springer.
   Google Scholar
• Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, et al. 2006. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 3:11.
   PubMed Web of Science ®Google Scholar
• Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2:MR17–MR71.
   PubMed Web of Science ®Google Scholar
• Cassee FR, Muijser H, Duistermaat E, Freijer JJ, Geerse KB, Marijnissen JC, Arts JH. 2002. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol. 76:277–286.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A. 1997. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Release. 45:211–226.
   Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. 1998. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1368:201–215.
   PubMed Web of Science ®Google Scholar
• Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique N, Alving C, Muggia F. 2003. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions. Ann Oncol. 14:1430–1437.
   PubMed Web of Science ®Google Scholar
• Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC. 2013. Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv. 10:845–856.
   PubMed Web of Science ®Google Scholar
• Choi AO, Brown SE, Szyf M, Maysinger D. 2008. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J Mol Med. 86:291–302.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Kang SJ, Kim YJ, Lim Yb, Chung HW. 2010. Comparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cells. Drug Chem Toxicol. 33:357–366.
   PubMed Web of Science ®Google Scholar
• Chou LY, Ming K, Chan WC. 2011. Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev. 40:233–245.
   PubMed Web of Science ®Google Scholar
• Chuang SY, Lin CH, Huang TH, Fang JY. 2018. Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials. 8:42.
   Web of Science ®Google Scholar
• Cole MP, Jones C, Todd I. 1971. A new anti-oestrogenic agent in late breast cancer: an early clinical appraisal of ICI46474. Br J Cancer. 25:270–275.
   PubMed Web of Science ®Google Scholar
• Collins AR. 2004. The comet assay for DNA damage and repair. Mol Biotechnol. 26:249–261.
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Monavari H, Ebrahimi S. 2012. Preparation and characterization of acyclovir loaded nano-niosomes as a potential antiviral drug delivery system. Res Pharm Sci. 7:232.
   Google Scholar
• Davis ME, Chen Z, Shin DM. 2010. Nanoparticle therapeutics: an emerging treatment modality for cancered.. In: Rodgers P, editor. Nanoscience and technology: a collection of reviews from nature journals. Singapore: World Scientific. p. 239–250.
   Google Scholar
• Decuypere J, Dierick N. 2003. The combined use of triacylglycerols containing medium-chain fatty acids and exogenous lipolytic enzymes as an alternative to in-feed antibiotics in piglets: concept, possibilities and limitations. An overview. Nutr Res Rev. 16:193–210.
   PubMed Web of Science ®Google Scholar
• DeMarini DM, Brockman HE, de Serres FJ, Evans HH, Stankowski LF Jr, Hsie AW. 1989. Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective. Mutat Res. 220:11–29.
   PubMed Web of Science ®Google Scholar
• Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu Rev Biochem. 78:857–902.
   PubMed Web of Science ®Google Scholar
• Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y. 2000. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res. 17:521–525.
   PubMed Web of Science ®Google Scholar
• Doktorovová S, Santos DL, Costa I, Andreani T, Souto EB, Silva AM. 2014. Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells. Int J Pharm. 471:18–27.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Silva AM, Gaivão I, Souto EB, Teixeira JP, Martins‐Lopes P. 2014. Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles. J Appl Toxicol. 34:395–403.
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V. 2003. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Dell’Istituto Superiore di sanitÃ. 39:405–410.
   PubMedGoogle Scholar
• Ehterami A, Salehi M, Farzamfar S, Samadian H, Vaez A, Ghorbani S, Ai J, Sahrapeyma H. 2019. Chitosan/alginate hydrogels containing Alpha-tocopherol for wound healing in rat model. J Drug Deliv Sci Technol. 51:204–213.
   Web of Science ®Google Scholar
• Ekambaram P, Sathali AAH, Priyanka K. 2012. Solid lipid nanoparticles: a review. Sci Rev Chem Commun. 2:80–102.
   Web of Science ®Google Scholar
• Elmore S. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol. 35:495–516.
   PubMed Web of Science ®Google Scholar
• Eskandani M, Nazemiyeh H. 2014. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation. Eur J Pharm Sci. 59:49–57.
   PubMed Web of Science ®Google Scholar
• Esterbauer H. 1993. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr. 57:779S–786S.
   PubMed Web of Science ®Google Scholar
• Fang CL, A Al-Suwayeh S, Fang JY. 2013. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Patents Nanotechnol. 7:41–55.
   PubMed Web of Science ®Google Scholar
• Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc. 2:1084–1104.
   PubMed Web of Science ®Google Scholar
• Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 5:161–171.
   PubMed Web of Science ®Google Scholar
• Filion MC, Phillips NC. 1997. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta. 1329:345–356.
   PubMed Web of Science ®Google Scholar
• Florea AM, Splettstoesser F, Büsselberg D. 2007. Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol Appl Pharmacol. 220:292–301.
   PubMed Web of Science ®Google Scholar
• Foroozandeh P, Aziz AA. 2018. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett. 13:339.
   PubMed Web of Science ®Google Scholar
• Freimark BD, Blezinger HP, Florack VJ, Nordstrom JL, Long SD, Deshpande DS, Nochumson S, Petrak KL. 1998. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J Immunol. 160:4580–4586.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T. 2009. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Pharm Res. 26:382–394.
   PubMed Web of Science ®Google Scholar
• Garg NK, Singh B, Tyagi RK, Sharma G, Katare OP. 2016. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model. Colloids Surf B Biointerfaces. 147:17–24.
   PubMed Web of Science ®Google Scholar
• Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:493–501.
   PubMed Web of Science ®Google Scholar
• Gharagozloo P, Gutiérrez-Adán A, Champroux A, Noblanc A, Kocer A, Calle A, Pérez-Cerezales S, Pericuesta E, Polhemus A, Moazamian A, et al. 2016. A novel antioxidant formulation designed to treat male infertility associated with oxidative stress: promising preclinical evidence from animal models. Hum Reprod. 31:252–262.
   PubMed Web of Science ®Google Scholar
• Gjetting T, Andresen TL, Christensen CL, Cramer F, Poulsen TT, Poulsen HS. 2011. A simple protocol for preparation of a liposomal vesicle with encapsulated plasmid DNA that mediate high accumulation and reporter gene activity in tumor tissue. Results Pharma Sci. 1:49–56.
   PubMedGoogle Scholar
• Gupta A, Aggarwal G, Singla S, Arora R. 2012. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation. Sci Pharm. 80:1061–1080.
   PubMedGoogle Scholar
• Hann IM, Prentice HG. 2001. Lipid-based amphotericin B: a review of the last 10 years of use. Int J Antimicrob Agents. 17:161–169.
   PubMed Web of Science ®Google Scholar
• Hashim F, El-Ridy M, Nasr M, Abdallah Y. 2010. Preparation and characterization of niosomes containing ribavirin for liver targeting. Drug Deliv. 17:282–287.
   PubMed Web of Science ®Google Scholar
• Hawksworth GM. 1994. Advantages and disadvantages of using human cells for pharmacological and toxicological studies. Hum Exp Toxicol. 13:568–573.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Noguchi Y, Harashima H. 2012. Non-linear pharmacokinetics of octaarginine-modified lipid nanoparticles: barriers from in vitro to in vivo. J Control Release. 161:757–762.
   PubMed Web of Science ®Google Scholar
• Honda K, Enoshima T, Oshikata T, Kamiya K, Hamamura M, Yamaguchi N, Nakamura K, Oguma Y, Fujiwara S, Takabe M, et al. 2009. Toxicity studies of Asahi Kasei PI, purified phosphatidylinositol from soy lecithin. J Toxicol Sci. 34:265–280.
   PubMed Web of Science ®Google Scholar
• Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E. 1999. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 87:700–705.
   PubMed Web of Science ®Google Scholar
• Hua S. 2014. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund’s Adjuvant rodent model of acute inflammatory pain. Pain Physician. 17:E719–E735.
   PubMed Web of Science ®Google Scholar
• Huang YW, Cambre M, Lee HJ. 2017. The toxicity of nanoparticles depends on multiple molecular and physicochemical mechanisms. IJMS. 18:2702.
   Google Scholar
• Huang M, Khor E, Lim LY. 2004. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res. 21:344–353.
   PubMed Web of Science ®Google Scholar
• Huerta S, Goulet EJ, Huerta-Yepez S, Livingston EH. 2007. Screening and detection of apoptosis. J Surg Res. 139:143–156.
   PubMed Web of Science ®Google Scholar
• Huynh NT, Passirani C, Saulnier P, Benoit JP. 2009. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 379:201–209.
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J. 2012. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 20:813–830.
   PubMed Web of Science ®Google Scholar
• Ivashkevich A, Redon CE, Nakamura AJ, Martin RF, Martin OA. 2012. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett. 327:123–133.
   PubMed Web of Science ®Google Scholar
• Jain KK, Jain KK. 2008. The handbook of nanomedicine. Berlin: Springer.
   Google Scholar
• Jamal M, Imam SS, Aqil M, Amir M, Mir SR, Mujeeb M. 2015. Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems. Int Immunopharmacol. 29:361–369.
   PubMed Web of Science ®Google Scholar
• James N, Coker R, Tomlinson D, Harris J, Gompels M, Pinching A, Stewart J. 1994. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi’s sarcoma in AIDS. Clin Oncol. 6:294–296.
   PubMedGoogle Scholar
• Jennifer M, Maciej W. 2013. Nanoparticle technology as a double-edged sword: cytotoxic, genotoxic and epigenetic effects on living cells. JBNB. 04:53–63.
   Google Scholar
• Johnson GE. 2012. Mammalian cell HPRT gene mutation assay: test methodsed. In: Genetic toxicology. Berlin: Springer, p. 55–67.
   Google Scholar
• Jorstad IS. 2016. Optimization, cellular uptake and cytotoxicity of lipid nanoparticlesed. MS thesis. NTNU.
   Google Scholar
• Kassie F, Parzefall W, Knasmüller S. 2000. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat Res. 463:13–31.
   PubMed Web of Science ®Google Scholar
• Kawadkar J, Pathak A, Kishore R, Chauhan MK. 2013. Formulation, characterization and in vitro–in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Drug Dev Ind Pharm. 39:569–578.
   PubMed Web of Science ®Google Scholar
• Khoshnevisan K, Daneshpour M, Barkhi M, Gholami M, Samadian H, Maleki H. 2018. The promising potentials of capped gold nanoparticles for drug delivery systems. J Drug Target. 26:525–532.
   PubMed Web of Science ®Google Scholar
• Kim JA, Lee N, Kim BH, Rhee WJ, Yoon S, Hyeon T, Park TH. 2011. Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials. 32:2871–2877.
   PubMed Web of Science ®Google Scholar
• Kirch W. 2008. Encyclopedia of public health. Dordrecht: Springer Science & Business Media. (A–H, I–Z; vols. 1–2).
   Google Scholar
• Knudsen KB, Northeved H, Kumar Ek P, Permin A, Gjetting T, Andresen TL, Larsen S, Wegener KM, Lykkesfeldt J, Jantzen K, et al. 2015. In vivo toxicity of cationic micelles and liposomes. Nanomedicine. 11:467–477.
   PubMed Web of Science ®Google Scholar
• Korkmaz KS, Butuner BD, Roggenbuck D. 2018. Detection of 8-OHdG as a diagnostic biomarker. J Lab Precis Med. 3:95–103.
   Google Scholar
• Kostarelos K, Miller AD. 2005. Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev. 34:970–994.
   PubMed Web of Science ®Google Scholar
• Kreuter J. 2004. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol. 4:484–488.
   PubMed Web of Science ®Google Scholar
• Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. 2011. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 711:193–201.
   PubMed Web of Science ®Google Scholar
• Küchler S, Herrmann W, Panek-Minkin G, Blaschke T, Zoschke C, Kramer KD, Bittl R, Schäfer-Korting M. 2010. SLN for topical application in skin diseases—characterization of drug–carrier and carrier–target interactions. Int J Pharm. 390:225–233.
   PubMed Web of Science ®Google Scholar
• Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD. 2009. Nanoparticles for skin penetration enhancement—a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm. 71:243–250.
   PubMed Web of Science ®Google Scholar
• Kuhlbusch TA, Asbach C, Fissan H, Göhler D, Stintz M. 2011. Nanoparticle exposure at nanotechnology workplaces: a review. Part Fibre Toxicol. 8:22.
   PubMed Web of Science ®Google Scholar
• Kuhn DA, Vanhecke D, Michen B, Blank F, Gehr P, Petri-Fink A, Rothen-Rutishauser B. 2014. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J Nanotechnol. 5:1625–1636.
   PubMed Web of Science ®Google Scholar
• Kumar Sarwa K, Rudrapal M, Mazumder B. 2015. Topical ethosomal capsaicin attenuates edema and nociception in arthritic rats. Drug Deliv. 22:1043–1052.
   PubMed Web of Science ®Google Scholar
• Lai SK, Hida K, Man ST, Chen C, Machamer C, Schroer TA, Hanes J. 2007. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials. 28:2876–2884.
   PubMed Web of Science ®Google Scholar
• Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. 2002. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation. 106:2842–2847.
   PubMed Web of Science ®Google Scholar
• Lara Y, Nguyen T, Marilena L, Alexander M. 2011. Toxicological considerations of clinically applicable nanoparticles. Nano Today. 6:585–607.
   PubMed Web of Science ®Google Scholar
• Le Roux G, Moche H, Nieto A, Benoit JP, Nesslany F, Lagarce F. 2017. Cytotoxicity and genotoxicity of lipid nanocapsules. Toxicol In Vitro. 41:189–199.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim JS, Oh YK, Lee YB, Sah H. 2005. Biodistribution and genotoxicity of transferrin-conjugated liposomes/DNA complexes in mice. Macromol Res. 13:218–222.
   Web of Science ®Google Scholar
• Lee RJ, Low PS. 1994. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem. 269:3198–3204.
   PubMed Web of Science ®Google Scholar
• Li Q, Cai T, Huang Y, Xia X, Cole S, Cai Y. 2017. A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials. 7:122.
   Web of Science ®Google Scholar
• Li JJe, Muralikrishnan S, Ng CT, Yung LYL, Bay BH. 2010. Nanoparticle-induced pulmonary toxicity. Exp Biol Med (Maywood). 235:1025–1033.
   PubMed Web of Science ®Google Scholar
• Lim SB, Banerjee A, Önyüksel H. 2012. Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release. 163:34–45.
   PubMed Web of Science ®Google Scholar
• Lin PJ, Tam YYC, Hafez I, Sandhu A, Chen S, Ciufolini MA, Nabi IR, Cullis PR. 2013. Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA. Nanomedicine. 9:233–246.
   PubMed Web of Science ®Google Scholar
• Liu D, Liu Z, Wang L, Zhang C, Zhang N. 2011. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces. 85:262–269.
   PubMed Web of Science ®Google Scholar
• Löbrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, Barton O, Jeggo PA. 2010. γH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle. 9:662–669.
   PubMed Web of Science ®Google Scholar
• Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E. 2003. Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model. J Control Release. 93:377–387.
   PubMed Web of Science ®Google Scholar
• Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, Qin J, Cantley W, Qin LL, Racie T, et al. 2010. Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA. 107:1864–1869.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA. 105:14265–14270.
   PubMed Web of Science ®Google Scholar
• Lv H, Zhang S, Wang B, Cui S, Yan J. 2006. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 114:100–109.
   PubMed Web of Science ®Google Scholar
• Madureira AR, Nunes S, Campos DA, Fernandes JC, Marques C, Zuzarte M, Gullón B, Rodríguez-Alcalá LM, Calhau C, Sarmento B. 2016. Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches. Int J Nanomedicine. 11:3621.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Meng J, Xue X, Liang XJ, Rahman M, Pfeiffer C, Hartmann R, Gil PR, Pelaz B, Parak WJ, et al. 2014. Interaction of stable colloidal nanoparticles with cellular membranes. Biotechnol Adv. 32:679–692.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46:6387–6392.
   PubMed Web of Science ®Google Scholar
• Maupas C, Moulari B, Béduneau A, Lamprecht A, Pellequer Y. 2011. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells. Int J Pharm. 411:136–141.
   PubMed Web of Science ®Google Scholar
• McCarthy NJ, Evan GI. 1997. 15 Methods for detecting and quantifying apoptosised. In: de Pablo F, Ferrús A, Stern CD, editors. Cellular and molecular procedures in developmental biology. San Diego (CA): Academic Press; p. 259–278. (Current topics in developmental biology; vol. 36).
   Google Scholar
• McQueen C. 2017. Comprehensive toxicology. Amsterdam: Elsevier.
   Google Scholar
• Mehnert W, Mäder K. 2012. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 64:83–101.
   Web of Science ®Google Scholar
• Mei Z, Wu Q, Hu S, Lib X, Yang X. 2005. Triptolide loaded solid lipid nanoparticle hydrogel for topical application. Drug Dev Ind Pharm. 31:161–168.
   PubMed Web of Science ®Google Scholar
• Miller AD. 2008. Towards safe nanoparticle technologies for nucleic acid therapeutics. Tumori J. 94:234–245.
   PubMed Web of Science ®Google Scholar
• Miller AD. 2013a. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 10:781–811.
   PubMed Web of Science ®Google Scholar
• Miller AD. 2013b. Lipid-based nanoparticles in cancer diagnosis and therapy. J Drug Deliv. 2013:1–9.
   Google Scholar
• Modi C, Bharadia P. 2012. Transfersomes: new dominants for transdermal drug delivery. Am J Pharm Tech Res. 2:71–91.
   Google Scholar
• Moghassemi S, Hadjizadeh A. 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 185:22–36.
   PubMed Web of Science ®Google Scholar
• Mortelmans K, Zeiger E. 2000. The Ames Salmonella/microsome mutagenicity assay. Mutat Res. 455:29–60.
   PubMed Web of Science ®Google Scholar
• Mortezaee K, Najafi M, Samadian H, Barabadi H, Azarnezhad A, Ahmadi A. 2019. Redox interactions and genotoxicity of metal-based nanoparticles: a comprehensive review. Chem-Biol Interact. 312:108814.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 54:S131–S155.
   PubMed Web of Science ®Google Scholar
• Murgia S, Falchi AM, Mano M, Lampis S, Angius R, Carnerup AM, Schmidt J, Diaz G, Giacca M, Talmon Y, et al. 2010. Nanoparticles from lipid-based liquid crystals: emulsifier influence on morphology and cytotoxicity. J Phys Chem B. 114:3518–3525.
   PubMed Web of Science ®Google Scholar
• Murphy MP. 2009. How mitochondria produce reactive oxygen species. Biochem J. 417:1–13.
   PubMed Web of Science ®Google Scholar
• Murthy SK. 2007. Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomedicine. 2:129–141.
   PubMed Web of Science ®Google Scholar
• Naahidi S, Jafari M, Edalat F, Raymond K, Khademhosseini A, Chen P. 2013. Biocompatibility of engineered nanoparticles for drug delivery. J Control Release. 166:182–194.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, Nakanishi M, Tanaka K, Mayumi T. 1999. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Control Release. 61:233–240.
   PubMed Web of Science ®Google Scholar
• Nandhakumar S, Parasuraman S, Shanmugam M, Rao KR, Chand P, Bhat BV. 2011. Evaluation of DNA damage using single-cell gel electrophoresis (Comet Assay). J Pharmacol Pharmacother. 2:107.
   PubMedGoogle Scholar
• Nandure HP, Puranik P, Giram P, Lone V. 2013. Ethosome: a novel drug carrier. Int J Pharmaceut Res Allied Sci. 2:18–30.
   Google Scholar
• Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB. 2010. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces. 81:263–273.
   PubMed Web of Science ®Google Scholar
• Newman MS, Colbern GT, Working PK, Engbers C, Amantea MA. 1999. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother Pharmacol. 43:1–7.
   PubMed Web of Science ®Google Scholar
• Ng CT, Li JJ, Bay BH, Yung LYL. 2010. Current studies into the genotoxic effects of nanomaterials. J Nucleic Acids. 2010:1–12.
   Google Scholar
• Nie S, Xing Y, Kim GJ, Simons JW. 2007. Nanotechnology applications in cancer. Annu Rev Biomed Eng. 9:257–288.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Iwakiri N, Kaneko Y, Taguchi A, Fukushima K, Mori H, Morone N, Kadokawa JI. 2009. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules. 10:2074–2085.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113:823–839.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2:8.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Barar J, Heidari HR, Ahmadian S, Yazdi HA, Akhtar S. 2008. Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cells. Toxicol Mech Methods. 18:369–378.
   PubMed Web of Science ®Google Scholar
• Ostling O, Johanson KJ. 1984. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun. 123(1):291–298.
   PubMed Web of Science ®Google Scholar
• Orlando A, Re F, Sesana S, Rivolta I, Panariti A, Brambilla D, Nicolas J, Couvreur P, Andrieux K, Masserini M, et al. 2013. Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages. Int J Nanomedicine. 8:1335–1347.
   PubMed Web of Science ®Google Scholar
• Ozaki T, Nakagawara A. 2011. Role of p53 in cell death and human cancers. Cancers. 3:994–1013.
   PubMedGoogle Scholar
• Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. 2005. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 106:99–110.
   PubMed Web of Science ®Google Scholar
• Parashar T, Sachan R, Singh V, Singh G, Tyagi S, Patel C, Gupta A. 2013. Ethosomes: a recent vesicle of transdermal drug delivery system. Int J Res Dev Pharm Life Sci. 2:285–292.
   Google Scholar
• Patel R, Singh S, Singh S, Sheth N, Gendle R. 2009. Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res. 1:71.
   Google Scholar
• Pelkmans L, Helenius A. 2002. Endocytosis via caveolae. Traffic. 3:311–320.
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. 2010. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 9:615–627.
   PubMed Web of Science ®Google Scholar
• Podhorecka M, Skladanowski A, Bozko P. 2010. H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucleic Acids. 2010:1–9.
   Google Scholar
• Pridgen EM, Alexis F, Farokhzad OC. 2015. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv. 12:1459–1473.
   PubMed Web of Science ®Google Scholar
• Prosperi D, Colombo M, Zanoni I, Granucci F. 2017. Drug nanocarriers to treat autoimmunity and chronic inflammatory diseasesed. Semin Immunol. 34:61–67.
   PubMed Web of Science ®Google Scholar
• Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. 2009. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Therapeutic Drug Carrier Syst. 26:523–580.
   PubMed Web of Science ®Google Scholar
• Raemdonck K, Remaut K, Lucas B, Sanders NN, Demeester J, De Smedt SC. 2006. In situ analysis of single-stranded and duplex siRNA integrity in living cells. Biochemistry. 45:10614–10623.
   PubMed Web of Science ®Google Scholar
• Rajera R, Nagpal K, Singh SK, Mishra DN. 2011. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 34:945–953.
   PubMed Web of Science ®Google Scholar
• Rivolta I, Panariti A, Lettiero B, Sesana S, Gasco P, Gasco M, Masserini M, Miserocchi G. 2011. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. J Physiol Pharmacol. 62:45–53.
   PubMed Web of Science ®Google Scholar
• Roursgaard M, Knudsen KB, Northeved H, Persson M, Christensen T, Kumar PEK, Permin A, Andresen TL, Gjetting T, Lykkesfeldt J, et al. 2016. In vitro toxicity of cationic micelles and liposomes in cultured human hepatocyte (HepG2) and lung epithelial (A549) cell lines. Toxicol In Vitro. 36:164–171.
   PubMed Web of Science ®Google Scholar
• Rydberg B, Johanson KJ. 1978. Estimation of DNA strand breaks in single mammalian cells. In: DNA repair mechanisms. Academic Press; p. 465–468.
   Google Scholar
• Saadat YR, Saeidi N, Vahed SZ, Barzegari A, Barar J. 2015. An update to DNA ladder assay for apoptosis detection. Bioimpacts. 5:25.
   PubMed Web of Science ®Google Scholar
• Saeidnia S, Manayi A, Abdollahi M. 2016. From in vitro experiments to in vivo and clinical studies; pros and cons. Curr Drug Discov Technol. 12:218–224.
   Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. 2010. Endocytosis of nanomedicines. J Control Release. 145:182–195.
   PubMed Web of Science ®Google Scholar
• Salunkhe SS, Bhatia NM, Pokharkar VB, Thorat JD, Bhatia MS. 2013. Topical delivery of Idebenone using nanostructured lipid carriers: evaluations of sun-protection and anti-oxidant effects. J Pharm Investig. 43:287–303.
   Google Scholar
• Samadian H, Mobasheri H, Hasanpour S, Faridi-Majid R. 2017. Needleless electrospinning system, an efficient platform to fabricate carbon nanofibersed. J Nano Res. 181:78–89.
   Google Scholar
• Scarfì MR. 2004. The cytokinesis-block micronucleus assay: experimental procedure and application in bioelectromagnetics research. Electromagn Sending Environ. 27:460–466.
   Google Scholar
• Scheule RK, George JAS, Bagley RG, Marshall J, Kaplan JM, Akita GY, Wang KX, Lee ER, Harris DJ, Jiang C, et al. 1997. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther. 8:689–707.
   PubMed Web of Science ®Google Scholar
• Schins RP, Knaapen AM. 2007. Genotoxicity of poorly soluble particles. Inhal Toxicol. 19:189–198.
   PubMed Web of Science ®Google Scholar
• Schneider S, Lenz D, Holzer M, Palme K, Süss R. 2010. Intracellular FRET analysis of lipid/DNA complexes using flow cytometry and fluorescence imaging techniques. J Control Release. 145:289–296.
   PubMed Web of Science ®Google Scholar
• Seaton A, Tran L, Aitken R, Donaldson K. 2009. Nanoparticles, human health hazard and regulation. J R Soc Interface. 7:S119–S129.
   PubMed Web of Science ®Google Scholar
• Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DWY, Stebbing D, Crosley E J, Yaworski E, et al. 2010. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 28:172–176.
   PubMed Web of Science ®Google Scholar
• Shafaei A, Esmailli K, Farsi E, Aisha AF, Majid A, Ismail Z. 2015. Genotoxicity, acute and subchronic toxicity studies of nano liposomes of Orthosiphon stamineus ethanolic extract in Sprague Dawley rats. BMC Complement Altern Med. 15:360.
   PubMed Web of Science ®Google Scholar
• Shah V, Taratula O, B Garbuzenko O, L Patil M, Savla R, Zhang M, Minko T. 2013. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Curr Drug Discov Technol. 10:8–15.
   PubMedGoogle Scholar
• Shaheen SM, Akita H, Yamashita A, Katoono R, Yui N, Biju V, Ishikawa M, Harashima H. 2011. Quantitative analysis of condensation/decondensation status of pDNA in the nuclear sub-domains by QD-FRET. Nucleic Acids Res. 39:e48.
   PubMed Web of Science ®Google Scholar
• Sharifi S, Behzadi S, Laurent S, Forrest ML, Stroeve P, Mahmoudi M. 2012. Toxicity of nanomaterials. Chem Soc Rev. 41:2323–2343.
   PubMed Web of Science ®Google Scholar
• Sheo D, Shweta A, Vijay K, Ram C, Aklavya S, Ghanshyam M. 2010. Enhanced transdermal delivery of indinavir sulfate via transfersomes. Pharmacie Globale (IJCP). 1:1–7.
   Google Scholar
• Shi B, Keough E, Matter A, Leander K, Young S, Carlini E, Sachs AB, Tao W, Abrams M, Howell B. 2011. Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery. J Histochem Cytochem. 59:727–740.
   PubMed Web of Science ®Google Scholar
• Shin S, Kwon HM, Yoon KS, Kim DE, Hah SS. 2011. FRET-based probing to gain direct information on siRNA sustainability in live cells: asymmetric degradation of siRNA strands. Mol Biosyst. 7:2110–2113.
   PubMedGoogle Scholar
• Siegrist M, Wiek A, Helland A, Kastenholz H. 2007. Risks and nanotechnology: the public is more concerned than experts and industry. Nat Nanotechnol. 2:67.
   PubMed Web of Science ®Google Scholar
• Singh N, Manshian B, Jenkins GJ, Griffiths SM, Williams PM, Maffeis TG, Wright CJ, Doak SH. 2009. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials. 30:3891–3914.
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191.
   PubMed Web of Science ®Google Scholar
• Slowinski J, Bierzynska-Macyszyn G, Mazurek U, Widel M, Latocha M, Stomal M, Snietura M, Mrowka R. 2011. Cytokinesis-block micronucleus assay in human glioma cells exposed to radiation. Image Anal Stereol. 23:159–165.
   Google Scholar
• Snipstad S, Westrøm S, Mørch Y, Afadzi M, Åslund AK, de Lange Davies C. 2014. Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles. Cancer Nano. 5. Article number: 8.
   PubMedGoogle Scholar
• Soenen SJ, Brisson AR, De Cuyper M. 2009. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials. 30:3691–3701.
   PubMed Web of Science ®Google Scholar
• Solarska K, Gajewska A, Kaczorowski W, Bartosz G, Mitura K. 2012. Effect of nanodiamond powders on the viability and production of reactive oxygen and nitrogen species by human endothelial cells. Diam Relat Mater. 21:107–113.
   Web of Science ®Google Scholar
• Souto EB, Martins-Lopes P, Lopes CM, Gaivão I, Silva AM, Guedes-Pinto H. 2009. A note on regulatory concerns and toxicity assessment in lipid-based delivery systems (LDS). J Biomed Nanotechnol. 5:317–322.
   PubMed Web of Science ®Google Scholar
• Spagnou S, Miller AD, Keller M. 2004. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry. 43:13348–13356.
   PubMed Web of Science ®Google Scholar
• Srinivas PR, Barker P, Srivastava S. 2002. Nanotechnology in early detection of cancer. Rockefeller University Press.
   Google Scholar
• Steinman RM, Mellman IS, Muller WA, Cohn ZA. 1983. Endocytosis and the recycling of plasma membrane. J Cell Biol. 96:1–27.
   PubMed Web of Science ®Google Scholar
• Studzinski GP. 1999. Apoptosis: a practical approach. Taylor & Francis.
   Google Scholar
• Szebeni J, Alving CR, Rosivall L, Bünger R, Baranyi L, Bedöcs P, Tóth M, Barenholz Y. 2007. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res. 17:107–117.
   PubMed Web of Science ®Google Scholar
• Tan A, Hong L, Du JD, Boyd BJ. 2019. Self‐assembled nanostructured lipid systems: is there a link between structure and cytotoxicity? Adv Sci. 6:1801223.
   Web of Science ®Google Scholar
• Thanou M, Duncan R. 2003. Polymer-protein and polymer-drug conjugates in cancer therapy. Curr Opin Investig Drugs. 4:701–709.
   PubMedGoogle Scholar
• Thassu D, Deleers M, Pathak YV. 2007. Nanoparticulate drug delivery systems. London: CRC Press.
   Google Scholar
• Thomas P, Fenech M. 2011. Cytokinesis-block micronucleus cytome assay in lymphocytes. In: Didenko V, editor. DNA damage detection in situ, ex vivo, and in vivo. Totowa, NJ: Humana Press; p. 217–234. (Methods in Molecular Biology (Methods and Protocols); vol. 682).
   Google Scholar
• Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki Y. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 35:206–221.
   PubMed Web of Science ®Google Scholar
• Touitou E, Godin B, Shumilov M, Bishouty N, Ainbinder D, Shouval R, Ingber A, Leibovici V. 2008. Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris. J Eur Acad Dermatol Venerol. 22:621–629.
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. 2004. Deformable liposomes for dermal administration of methotrexate. Int J Pharm. 270:119–125.
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 172:33–70.
   Web of Science ®Google Scholar
• Ulbrich W, Lamprecht A. 2009. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J R Soc Interface. 7:S55–S66.
   PubMed Web of Science ®Google Scholar
• Urata K, Narahara H, Tanaka Y, Egashira T, Takayama F, Miyakawa I. 2001. Effect of endotoxin-induced reactive oxygen species on sperm motility. Fertil Steril. 76:163–166.
   PubMed Web of Science ®Google Scholar
• Uusitalo LM, Hempel N. 2012. Recent advances in intracellular and in vivo ROS sensing: focus on nanoparticle and nanotube applications. Int J Mol Sci. 13:10660–10679.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. 2009. 8-Hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health Part C. 27:120–139.
   Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi H, Andalib S. 2012. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers. Eur J Med Chem. 54:429–438.
   PubMed Web of Science ®Google Scholar
• Vemuri S, Rhodes C. 1995. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helvetiae. 70:95–111.
   PubMedGoogle Scholar
• Venkateswarlu V, Manjunath K. 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 95:627–638.
   PubMed Web of Science ®Google Scholar
• Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, Sanders NN, Braeckmans K. 2010. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther. 18:561–569.
   PubMed Web of Science ®Google Scholar
• Wang MD, Shin DM, Simons JW, Nie S. 2007. Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther. 7:833–837.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu B, Wu Y, Lee RJ, Lee LJ. 2011. Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery. Anticancer Res. 31:1619–1626.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu B, Ren W, Mo X, Zhou C, He H, Jia H, Wang L, Jacob ST, Lee RJ, et al. 2013. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release. 172:690–698.
   PubMed Web of Science ®Google Scholar
• Weyhers H, Ehlers S, Hahn H, Souto E, Müller R. 2006. Solid lipid nanoparticles (SLN)–effects of lipid composition on in vitro degradation and in vivo toxicity. Die Pharmazie-Int J Pharm Sci. 61:539–544.
   Google Scholar
• Wissing S, Kayser O, Müller R. 2004. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Wu Y, Ho YP, Mao Y, Wang X, Yu B, Leong KW, Lee LJ. 2011. Uptake and intracellular fate of multifunctional nanoparticles: a comparison between lipoplexes and polyplexes via quantum dot mediated Forster resonance energy transfer. Mol Pharm. 8:1662–1668.
   PubMedGoogle Scholar
• Xu YQ, Chen WR, Tsosie JK, Xie X, Li P, Wan JB, He CW, Chen MW. 2016. Niosome encapsulation of curcumin: characterization and cytotoxic effect on ovarian cancer cells. J Nanomater. 2016:1–9.
   Web of Science ®Google Scholar
• Xue M, Jiang ZZ, Wu T, Li J, Zhang L, Zhao Y, Li XJ, Zhang LY, Yang SY. 2012. Anti-inflammatory effects and hepatotoxicity of Tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats. Phytomedicine. 19:998–1006.
   PubMed Web of Science ®Google Scholar
• Yah CS, Iyuke SE, Simate GS. 2012. A review of nanoparticles toxicity and their routes of exposures. Iran J Pharm Sci. 8:299–314.
   Google Scholar
• Yang H, Liu C, Yang D, Zhang H, Xi Z. 2009. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 29:69–78.
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Q, Zhou X, Zhang N. 2008. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm. 352:273–279.
   PubMed Web of Science ®Google Scholar
• Yin H, Gong C, Shi S, Liu X, Wei Y, Qian Z. 2010. Toxicity evaluation of biodegradable and thermosensitive PEG‐PCL‐PEG hydrogel as a potential in situ sustained ophthalmic drug delivery system. J Biomed Mater Res. 92:129–137.
   Google Scholar
• Yoshida Y, Itoh N, Saito Y, Hayakawa M, Niki E. 2004. Application of water-soluble radical initiator, 2, 2′-azobis-[2-(2-imidazolin-2-yl) propane] dihydrochloride, to a study of oxidative stress. Free Radic Res. 38:375–384.
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. 1994. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 105:1–6.
   Web of Science ®Google Scholar
• Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, Ma GH. 2011. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules. 12:2440–2446.
   PubMed Web of Science ®Google Scholar
• Yu B, Hsu SH, Zhou C, Wang X, Terp MC, Wu Y, Teng L, Mao Y, Wang F, Xue W, et al. 2012. Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials. 33:5924–5934.
   PubMed Web of Science ®Google Scholar
• Yu B, Wang X, Zhou C, Teng L, Ren W, Yang Z, Shih CH, Wang T, Lee RJ, Tang S, et al. 2014. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm Res. 31:2685–2695.
   PubMed Web of Science ®Google Scholar
• Zasadzinski JA, Wong B, Forbes N, Braun G, Wu G. 2011. Novel methods of enhanced retention in and rapid, targeted release from liposomes. Curr Opin Colloid Interface Sci. 16:203–214.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Sadrieh N. 2009. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. Adv Drug Deliv Rev. 61:422–427.
   PubMed Web of Science ®Google Scholar
• Zur Mühlen A, Schwarz C, Mehnert W. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm. 45:149–155.
   PubMed Web of Science ®Google Scholar